Imricor Medical Systems, Inc. (IMR.AX)
AUD 1.25
(5.04%)
AUD 1.25
(5.04%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -22.62 Million AUD | -94.4% |
| 2022 | -17.53 Million USD | 14.7% |
| 2021 | -20.55 Million AUD | -57.2% |
| 2020 | -13.07 Million AUD | 11.63% |
| 2019 | -14.79 Million AUD | -102.79% |
| 2018 | -7.29 Million AUD | -8.74% |
| 2017 | -6.71 Million AUD | -22.13% |
| 2016 | -5.49 Million AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -3.42 Million USD | 48.84% |
| 2024 Q2 | -3.42 Million USD | 0.0% |
| 2023 Q1 | -4.6 Million USD | -21.62% |
| 2023 FY | -34.08 Million AUD | -94.4% |
| 2023 Q4 | -6.7 Million USD | 0.0% |
| 2023 Q3 | -6.7 Million USD | -45.4% |
| 2023 Q2 | -4.6 Million USD | 0.0% |
| 2022 FY | -17.53 Million USD | 14.7% |
| 2022 Q3 | -3.79 Million USD | 22.45% |
| 2022 Q2 | -4.88 Million USD | 0.0% |
| 2022 Q1 | -4.88 Million USD | -0.05% |
| 2022 Q4 | -3.79 Million USD | 0.0% |
| 2021 Q3 | -4.88 Million USD | 1.93% |
| 2021 Q4 | -4.88 Million USD | 0.0% |
| 2021 Q2 | -4.98 Million USD | 0.0% |
| 2021 FY | -20.55 Million AUD | -57.2% |
| 2021 Q1 | -4.98 Million USD | -49.83% |
| 2020 Q1 | -2.89 Million USD | 29.67% |
| 2020 Q3 | -3.32 Million USD | -14.69% |
| 2020 Q2 | -2.89 Million USD | 0.0% |
| 2020 Q4 | -3.32 Million USD | 0.0% |
| 2020 FY | -13.07 Million AUD | 11.63% |
| 2019 Q1 | -2.52 Million USD | -71.4% |
| 2019 FY | -14.79 Million AUD | -102.79% |
| 2019 Q4 | -4.12 Million USD | 0.0% |
| 2019 Q3 | -4.12 Million USD | -63.24% |
| 2019 Q2 | -2.52 Million USD | 0.0% |
| 2018 Q3 | -1.47 Million USD | -17.75% |
| 2018 Q1 | -1.25 Million USD | 0.0% |
| 2018 Q2 | -1.25 Million USD | 0.0% |
| 2018 Q4 | -1.47 Million USD | 0.0% |
| 2018 FY | -7.29 Million AUD | -8.74% |
| 2017 FY | -6.71 Million AUD | -22.13% |
| 2016 FY | -5.49 Million AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| 4DMedical Limited | -35.97 Million AUD | 37.113% |
| Adherium Limited | -10.22 Million AUD | -121.298% |
| Aroa Biosurgery Limited | -9.74 Million AUD | -132.102% |
| Atomo Diagnostics Limited | -6.84 Million AUD | -230.411% |
| Anteris Technologies Ltd | -67.33 Million AUD | 66.397% |
| Control Bionics Limited | -5.91 Million AUD | -282.596% |
| CardieX Limited | -6.76 Million AUD | -234.437% |
| Compumedics Limited | -338 Thousand AUD | -6594.054% |
| Cochlear Limited | 356.8 Million AUD | 106.341% |
| CleanSpace Holdings Limited | -3.12 Million AUD | -623.533% |
| Cyclopharm Limited | -4.7 Million AUD | -381.32% |
| EMVision Medical Devices Ltd | -2.72 Million AUD | -728.906% |
| Nova Eye Medical Limited | -8.79 Million AUD | -157.405% |
| HeraMED Limited | -6.78 Million AUD | -233.535% |
| ImpediMed Limited | -19.79 Million AUD | -14.33% |
| InhaleRx Limited | -1.44 Million AUD | -1467.682% |
| LBT Innovations Limited | -3.74 Million AUD | -504.971% |
| Micro-X Limited | -9.76 Million AUD | -131.704% |
| Neurotech International Limited | -5.06 Million AUD | -346.336% |
| OncoSil Medical Limited | -11.91 Million AUD | -89.916% |
| PolyNovo Limited | 5.26 Million AUD | 530.068% |
| Respiri Limited | -7.12 Million AUD | -217.367% |
| SomnoMed Limited | -12.24 Million AUD | -84.826% |
| Universal Biosensors, Inc. | -6.74 Million AUD | -235.618% |
| Uscom Limited | -2.07 Million AUD | -990.537% |
| Visioneering Technologies, Inc. | -5.06 Million AUD | -346.86% |